Blue Owl Capital Holdings’s ImageneBio Inc IMA Stock Holding History

Blue Owl Capital Holdings’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.41M	Sell	917,692 -41,645	-4%	-$235K	0.81%	22
2026 Q1	$4.8M	Buy	959,337 +135,552	+16%	+$880K	1.29%	19
2025 Q4	$5.68M	Buy	823,785 +282,861	+52%	+$2.1M	1.75%	19
2025 Q3	$4.41M	Buy	540,924 +199,997	+59%	+$2.65M	1.37%	22
2025 Q2	$5.48M	Hold	340,927	–	–	1.77%	15
2025 Q1	$5.24M	Hold	340,927	–	–	1.69%	16
2024 Q4	$6.71M	Hold	340,927	–	–	1.55%	16
2024 Q3	$7.08M	Hold	340,927	–	–	1.37%	20
2024 Q2	$6.75M	Buy	340,927 +16,667	+5%	+$294K	1.88%	17
2024 Q1	$5.53M	Buy	324,260 +161,459	+99%	+$2.94M	1.1%	21
2023 Q4	$3.85M	Buy	+162,801	New	+$5.31M	0.92%	22

Other funds holding IMA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Blue Owl Capital Holdings's IMA Position: Q2 2026 in Review

Blue Owl Capital Holdings reduced its ImageneBio Inc (IMA) stake by 4.3% in Q2 2026, selling an estimated $235K and leaving 917,692 shares worth $5.41M. The position accounts for 0.81% of the portfolio, ranked #22.

Blue Owl Capital Holdings first reported a position in IMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.08M in Q3 2024. 17 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

Blue Owl Capital Holdings held 917,692 shares of ImageneBio Inc worth $5.41M as of Q2 2026.
Blue Owl Capital Holdings sold 41,645 ImageneBio Inc shares in Q2 2026, an estimated $235K.
ImageneBio Inc made up 0.81% of Blue Owl Capital Holdings's portfolio in Q2 2026, its #22 holding.
Blue Owl Capital Holdings first reported a position in ImageneBio Inc in Q4 2023 and has held it in 11 quarters since.
Blue Owl Capital Holdings's ImageneBio Inc position peaked at $7.08M in Q3 2024.
17 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.